Digitisation | April 04, 2024
Aurigene introduces AI/ML assisted drug discovery platform
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Aurigene.AI is an end-to-end solution for small molecule drug discovery
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus
Lunaphore's flagship COMET technology is the only fully-automated, high-throughput, hyperplex platform with superior tissue profiling capabilities
Utidelone has the ability to cross BBB due to its unique physicochemical characteristic and insusceptibility to P-glycoprotein-mediated efflux
For the treatment of stenotic lesions of arteriovenous fistula in the haemodialysis management of chronic renal failure
This partnership combines Tata Elxsi's design and technology expertise along with Dräger's expertise in medical and safety technology
The CRDMO site will add 120,000L manufacturing capacity to WuXi Biologics’ global network
WINREVAIR is a breakthrough biologic for this rare, progressive disease
Oscotec has successfully completed phase 2 study in patients with chronic ITP last year
This new medication eliminates the need for cold storage, making it more accessible and affordable for SCD patients across India
Subscribe To Our Newsletter & Stay Updated
